Publication2025
Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells
The record
- Type
- Publication
- Date
- 29 January 2025
- Level
- International — held abroad
- Journal
- Rsc Pharmaceutics
- Volume
- 2
- Issue
- 3
- Pages
- 581-597
- Published
- 29 January 2025
- DOI
- 10.1039/d4pm00249k
- Scopus ID
- 105007041906
- ISSN
- 29768713
- Authors
- 6
- Open access
- Yes
- Citations
- 8
- International co-authorship
- Yes
- Co-author countries
- IN, IT
Classification
Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.
UN Sustainable Development Goals
3.4 Reduce premature mortality from non-communicable diseases and promote mental health and well-being
Gold nanoparticle-siRNA complexes demonstrate 78% Src protein downregulation in breast cancer cells, directly advancing tumor therapy.
- High confidence
- The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
- Judged
- Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
9.5 Enhance scientific research, upgrade technological capabilities, and increase researchers and R&D spending
Novel nanoparticle synthesis method for nucleic acid delivery represents research innovation in drug carrier design.
- Moderate confidence
- The alignment is plausible and defensible but rests on an assumption a reasonable reviewer could decline. Published, and surfaced in the review queue for a human to confirm or override.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
17.6 Enhance North-South, South-South and triangular cooperation on science, technology and innovation, and knowledge sharing
Structural signal: co-authorship outside India.
- Rule-derived
- Emitted by a deterministic rule from structural signals rather than judged from the record’s text. The rule carries a version, so rule-derived and judged labels stay separable.
- Produced by
- sdg17-structural-v1, under kortex-publication-v1
Viksit Bharat @2047
vb-1.2 Health and well-being
Cancer treatment research directly supports health and well-being outcomes through improved therapeutic mechanisms.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Each label above carries the instrument and the version that produced it. How each classification is reached.
Evidence
Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.
No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.
Provenance
Which source system this record came from, how many source rows were resolved into it, and when each was last read.
- Source rows resolved into this record
- 1
Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.
Citing this record
This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.
KIIT Deemed to be University. “Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells”. Kortex.
